Archives2019Vol. 59, No. 2pp. 200-204

Article

NOS Inhibitors as Agents for Prevention and Therapy of Combined Radiation-Thermal Injuries

Chesnakova E.A., Filimonova M.V., Makarchuk V.M., Samsonovа A.S., Коrneeva T.S., Shevchenko L.I., Surinova V.I., Filimonov A.S.

A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia

Abstract

A high efficiency of NOS inhibitors T1004 and T1023 is shown when they are used at low-toxic doses (1/8–1/12 LD16) on the model of a combined radiation-thermal injury (CRTI) by the criterion of 30-day survival of animals. CRTI included total body γ-irradiation at a dose of 7 Gy and then III B degree thermal burn of 10% body surface with the aid of powerful flash light. The use of T1004 5 min or 4 h after CRTI showed a statistically significant increase of the survival rate of animals up to 90–100%; life expectancy in the control group was 10.9 ± 5.6 days. The multiple (every 4 hours, on days 2, 5, 6) application of T1004 or T1023 after CRTI was accompanied by an increase in the survival of the experimental animals by 40%, whereas the survival rate was 20% in the control. Life expectancy in the control group did not differ statistically significantly with the group treated with Т1004 and it was 12.5 ± 9.5 days and 12.7 ± 7.4 days, whereas we observed the tendency to the increased life expectancy in the group treated with T1023: as compared to the control group it was 18.2 ± 6.9 days.

Keywords

Combined radiation-thermal injuries, NOS inhibitors, survival, treatment, death rate, life expectancy, Micе

Current Issue

FAQs

Can a manuscript be rejected if it is not prepared in accordance with the rules for preparation of manuscripts?

Yes, in this case the paper can be rejected.

Are the authors provided with pdf files of their articles?

Yes, authors are provided with pdf filesThe files are sent to the authors' addresses specified in the file "Information about authors".

all questions